Practical recommendations for the clinical evaluation of patients with hereditary ataxia and hereditary spastic

F J Arpa Gutiérrez1, M J Abenza Abildúa2, I Rouco Axpe3

  • 1Facultad de Medicina de la Universidad Autónoma de Madrid, Fundación IdiPAZ, Madrid, Spain; Comisión de Ataxias y Paraparesias Espásticas de la Sociedad Española de Neurología (CEAPED).

Neurologia
|November 17, 2022
PubMed

Insights

This study offers practical recommendations for diagnosing and managing rare hereditary ataxias (HA) and hereditary spastic paraplegias (HSP). It aims to standardize clinical criteria and disability assessments for these neurological conditions.

Area of Science:

  • Neurology
  • Rare Diseases
  • Genetics

Background:

  • Hereditary ataxia (HA) and hereditary spastic paraplegia (HSP) are rare neurological disorders.
  • These conditions are infrequently encountered in general neurology practice, leading to potential diagnostic and management challenges.

Purpose of the Study:

  • To provide practical, evidence-based recommendations for the diagnosis and management of HA and HSP.
  • To establish a standardized procedure for comprehensive disability evaluation in these patients.
  • To unify clinical criteria and assessment protocols for improved patient care.

Main Methods:

  • Development of practical guidelines based on current literature and expert consensus.
  • Definition of specific subtypes: HA and "HA plus," "pure" and "complicated" HSP.
  • Outline of clinical assessment, including key diagnostic tests and validated scales for physical and psychological evaluation.
  • Summary of current therapeutic options.

Main Results:

  • A set of brief, actionable recommendations for HA and HSP diagnosis and management.
  • A standardized protocol for comprehensive disability assessment.
  • Clear definitions and classification for HA and HSP subtypes.
  • Guidance on clinical evaluation, complementary tests, and assessment scales.

Conclusions:

  • These recommendations aim to simplify daily neurological practice for HA and HSP.
  • Standardization of clinical criteria and disability assessment will enhance consistency in patient management.
  • Facilitates better care for individuals affected by these rare neurological diseases.